342
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy

ORCID Icon, , , , , , , , , , , , , & show all
Article: FSO974 | Received 17 Dec 2023, Accepted 06 Feb 2024, Published online: 20 Feb 2024

References

  • Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: epidemiology of Helicobacter pylori infection. Helicobacter 24(Suppl. 1), e12635 (2019).
  • Hooi JKY, Lai WY, Ng WK et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2), 420–429 (2017).
  • Waskito LA, Yamaoka Y. The story of Helicobacter pylori: depicting human migrations from the phylogeography. Helicob. Pylor. Human Dis. 1149, 1–16 (2019).
  • Mansour KB, Keita A, Zribi M et al. Seroprevalence of Helicobacter pylori among Tunisian blood donors (outpatients), symptomatic patients and control subjects. Gastroenterol. Clin. Biol. 34(1), 75–82 (2010).
  • Siai K, Ghozzi M, Ezzine H, Medjahed N, Azzouz MM. Prevalence and risk factors of Helicobacter pylori infection in Tunisian children: 1055 children in Cap-Bon (northeastern Tunisia). Gastroenterol. Clin. Biol. 32(11), 881–886 (2008).
  • Safavi M, Sabourian R, Foroumadi A. Treatment of Helicobacter pylori infection: current and future insights. World J. Clin. Cases 4(1), 5–19 (2016).
  • Marcus EA, Sachs G, Scott DR. Eradication of Helicobacter pylori infection. Curr. Gastroenterol. Rep. 18(7), 33 (2016).
  • Gisbert JP, McNicholl AG. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter 22(4), e12392 (2017).
  • de Korwin J-D. Nouvelles recommandations sur la prise en charge des patients infectés par Helicobacter pylori. FMC-HGE (2020).
  • Liou JM, Chen PY, Kuo YT et al. Toward population specific and personalized treatment of Helicobacter pylori infection. J. Biomed. Sci. 25(1), 70 (2018).
  • Rossi A, Conti C, Colombo G et al. Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. Drug Dev. Ind. Pharm. 42(2), 332–339 (2016).
  • Gao CP, Zhou Z, Wang JZ, Han SX, Li LP, Lu H. Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: a systematic review and meta-analysis: high-dose dual rescue therapy for HP. J. Dig. Dis. 17(12), 811–819 (2016).
  • Liao XM. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection. World J. Gastroenterol. 21(20), 6310 (2015).
  • Zheng H-L, Hu Y-M, Bao J-J, Xu J-M. Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole. Acta Pharmacol. Sin. 31(4), 501–508 (2010).
  • Zullo A, Ridola L, Francesco VD et al. High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study. Ann. Gastroenterol. 28(4), 448–451 (2015).
  • Luo L, Ji Y, Yu L et al. 14-day high-dose amoxicillin- and metronidazole-containing triple therapy with or without bismuth as first-line Helicobacter pylori treatment. Dig. Dis. Sci. 65(12), 3639–3646 (2020).
  • Puig I, Baylina M, Sánchez-Delgado J et al. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment. J. Antimicrob. Chemother. 71(10), 2740–2753 (2016).
  • Song ZQ, Zhou LY. Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: a systematic review and meta-analysis. World J. Gastroenterol. 22(19), 4766–4775 (2016).
  • Itskoviz D, Boltin D, Leibovitzh H et al. Smoking increases the likelihood of Helicobacter pylori treatment failure. Dig. Liver Dis. 49(7), 764–768 (2017).
  • Peña-Galo E, Gotor J, Harb Y, Alonso M, Alcedo J. Socioeconomic and demographic factors associated with failure in Helicobacter pylori eradication using the standard triple therapy. Gastroenterol. Hepatol. Bed. Bench. 14(1), 53–58 (2021).